{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Denmark Specialty Chemicals news", "home_page_url": "https://sharemaestro.com/newsreel/dk/basic-materials/specialty-chemicals/", "feed_url": "https://sharemaestro.com/newsreel/dk/basic-materials/specialty-chemicals/feed.json", "description": "Latest Specialty Chemicals company headlines from Denmark, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:3af30d5147e0abf97da9be20011e6823f250b71129d265aa32a72112226f0145", "url": "https://finance.yahoo.com/markets/commodities/articles/novonesis-launches-optiva-triticum-help-111200660.html", "external_url": "https://finance.yahoo.com/markets/commodities/articles/novonesis-launches-optiva-triticum-help-111200660.html", "title": "Novonesis launches Optiva\u00ae Triticum to help pasta manufacturers navigate wheat volatility without compromising quality", "content_text": "Novonesis (Novozymes A/S) COPENHAGEN, Denmark, August 12, 2026 \u2013 Novonesis today announced the launch of Optiva\u00ae Triticum, a new biosolution that helps pasta manufacturers increase flexibility in wheat sourcing while maintaining the texture, firmness and eating experience consumers expect. As fluctuations in durum wheat availability and pricing continue to challenge the pasta industry, producers are seeking new ways to reduce raw material costs and strengthen supply resilience. Optiva\u00ae Triticum enables greater use of soft wheat flour in pasta applications while supporting consistent quality ac", "date_published": "2026-08-12T11:12:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Macro sensitivity", "NSIS-B"], "_sharemaestro": {"country": "Denmark", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "NSIS-B", "name": "Novozymes A/S", "sentiment_url": "https://sharemaestro.com/sentiment/11ec5f36-eff4-4b5e-be2f-2a6e445d852d/"}]}}, {"id": "source:a8dc7b75c918a6830a77cf3ca38e0112fa21b0d169ebb3695bde7a2b8baefbae", "url": "https://finance.yahoo.com/healthcare/articles/latest-global-microbial-biostimulants-market-073000815.html", "external_url": "https://finance.yahoo.com/healthcare/articles/latest-global-microbial-biostimulants-market-073000815.html", "title": "[Latest] Global Microbial Biostimulants Market Size/Share Worth USD 13.88 Billion by 2034 at a 10.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)", "content_text": "Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Microbial Biostimulants Market size & share revenue was valued at approximately USD 5.10 Billion in 2024 and is expected to reach USD 5.64 Billion in 2025 and is expected to reach around USD 13.88 Billion by 2034, at a CAGR of 10.5% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are BASF SE, Syngenta AG, Bayer AG, UPL Limited, Valagro S.p.A. (Syngenta Group), Isagro S.p.A. (Gowan G", "date_published": "2026-08-12T07:30:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Guidance", "NSIS-B"], "_sharemaestro": {"country": "Denmark", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "NSIS-B", "name": "Novozymes A/S", "sentiment_url": "https://sharemaestro.com/sentiment/11ec5f36-eff4-4b5e-be2f-2a6e445d852d/"}]}}, {"id": "source:a9903d411516303c53b0290de466fa10a62e4836a69cc7208db688a87307e57b", "url": "https://finance.yahoo.com/healthcare/articles/novonesis-acquire-remaining-share-microbiogen-072400235.html", "external_url": "https://finance.yahoo.com/healthcare/articles/novonesis-acquire-remaining-share-microbiogen-072400235.html", "title": "Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities", "content_text": "Novonesis (Novozymes A/S) Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities COPENHAGEN, Denmark, August 10 \u2013 Novonesis has signed an agreement with the intent to acquire MicroBioGen, an Australian biotechnology company with leading scientific expertise in yeast strains for industrial applications, particularly in bioethanol. The acquisition builds on Novonesis' 2013 investment in MicroBioGen and its current 23% stake, further strengthening a decade-long collaboration in advanced yeast solutions for bioethanol production. Ester Baiget, CEO: \"This acquisition m", "date_published": "2026-08-10T07:24:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "NSIS-B"], "_sharemaestro": {"country": "Denmark", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "NSIS-B", "name": "Novozymes A/S", "sentiment_url": "https://sharemaestro.com/sentiment/11ec5f36-eff4-4b5e-be2f-2a6e445d852d/"}]}}]}